NCT01805154

Brief Summary

The intent of this registry is to understand comprehensive clinical care strategies for Cardiac Resynchronization Therapy (CRT) patients especially non-responders in real-world clinical practice.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,529

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
9 countries

69 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2013

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 6, 2013

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

August 12, 2019

Completed
Last Updated

August 12, 2019

Status Verified

July 1, 2019

Enrollment Period

3.8 years

First QC Date

February 14, 2013

Results QC Date

October 23, 2018

Last Update Submit

July 1, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of CRT Non-responders Using 1) Clinical Composite Score (CCS) and 2) Site-specific Criteria for Determining CRT Response

    1. The CCS has 4 components: New York Heart Association (NYHA) functional classification, Patient Global Assessment (PGA), heart failure (HF) events, cardiovascular death. NYHA Class ranges from Class I (least severe) to Class IV (most severe); possible PGA responses are "markedly worse", "moderately worse", "slightly worse", "no change", "slightly better", "moderately better, "markedly better". CCS components were used to classify or score subjects as "IMPROVED" (at least one-class improvement in NYHA Class or improvement by PGA "moderately" or "markedly" better AND no HF events AND no cardiovascular death), or "WORSENED" (worsening in NYHA Class OR worsening by PGA "moderately" or "markedly" worse OR presence of HF events OR Cardiovascular death, or "UNCHANGED" (neither "improved" or "worsened"). Note CCS is not a numeric score. 2. Sites used their own clinical criteria (could include hospitalizations, functional assessments, etc.)

    6 months

  • Number of Subjects With Specfic Types of Symptom-based and Objective Definitions Used by Sites to Determine Patients' Response to CRT

    Number of subjects where sites used echocardiographic remodeling, clinical functional assessments, or clinical events to determine response status.

    6 months

  • Number of Subjects That Received Treatment Strategies for Heart Failure in the CRT Non-responder Population Between 6 and 12 Months

    Between 6 and 12 months

  • Number of Subjects Who Had an Improvement in NYHA Class Between Six Months and 12 Months

    Improvement in NYHA Class determined by improvement by at least 1 class.

    Between 6 and 12 months

Study Arms (1)

CRT patients

Patients who have received any market approved St Jude Medical CRT-D or CRT-P device

Device: CRT Patients

Interventions

This is a group of patients who are receiving bi-ventricular pacing therapy from CRT device.

Also known as: St Jude Medical, Any approved CRT device
CRT patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

HF patients with St. Jude Medical CRT devices

You may qualify if:

  • Patient willing and able to sign informed consent
  • Patients implanted with any market-approved St. Jude Medical CRT-D/P device with no prior LV lead placement

You may not qualify if:

  • Are likely to undergo heart transplantation within the next 12 months
  • Are less than 18 years of age
  • Are pregnant or planning to become pregnant during the duration of the study
  • Are currently participating in a clinical investigation that includes an active treatment arm
  • Have a life expectancy of less than 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (69)

Alabama Cardiovascular Group, P.C.

Birmingham, Alabama, 35205, United States

Location

*Heart Center Research, LLC.

Huntsville, Alabama, 35801, United States

Location

Cardiovascular Consultants Ltd

Glendale, Arizona, 85306, United States

Location

Cardiovascular Associates of Mesa

Mesa, Arizona, 85206, United States

Location

Phoenix Cardiovascular Research Group

Phoenix, Arizona, 85298, United States

Location

Southern Arizona VA Health Care System

Tucson, Arizona, 85723, United States

Location

Comprehensive Cardiovascular

Bakersfield, California, 93309, United States

Location

Chula Vista Cardiac Center

Chula Vista, California, 91910, United States

Location

Cardiac Rhythm Specialist

Northridge, California, 91325, United States

Location

Claudio Bonometti MD, Inc

Santa Barbara, California, 93101, United States

Location

The Cardiac & Vascular Institute Research Foundation, LLC

Gainesville, Florida, 32605, United States

Location

Cardiology Consultants - Baptist Campus

Pensacola, Florida, 32501, United States

Location

Tallahassee Research Institute

Tallahassee, Florida, 32308, United States

Location

VA Medical Center - Tampa

Tampa, Florida, 33612, United States

Location

Heartland Cardiovascular Center

Joliet, Illinois, 60451, United States

Location

Advocate Health and Hospitals Corporation

Oakbrook Terrace, Illinois, 60181, United States

Location

Unitypoint

Des Moines, Iowa, 50316, United States

Location

Heart Care Associates PSC

Madisonville, Kentucky, 42431, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

St. Elizabeth's Medical Center

Boston, Massachusetts, 02135, United States

Location

University of Michigan

Ann Arbor, Michigan, 48104, United States

Location

Cardiology Consultants of East Michigan

Flint, Michigan, 48532, United States

Location

*Thoracic Cardio Healthcare Found. (aka Sparrow Research)

Lansing, Michigan, 48912, United States

Location

Minneapolis Heart Institute

Minneapolis, Minnesota, 55407, United States

Location

Jackson Heart Clinic

Jackson, Mississippi, 39216, United States

Location

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

Location

Cardiology Associates of North Mississippi

Tupelo, Mississippi, 38801, United States

Location

St. Louis University Hospital

St Louis, Missouri, 63110, United States

Location

Deborah Heart and Lung Center

Browns Mills, New Jersey, 08015, United States

Location

Lourdes Cardiology Services

Cherry Hill, New Jersey, 08043, United States

Location

The Cleveland Clinic Foundation

Cleveland, Ohio, 44094, United States

Location

Genesis HealthCare System

Zanesville, Ohio, 43701, United States

Location

Saint Vincent Consultants in Cardiovascular Diseases

Erie, Pennsylvania, 16502, United States

Location

Mountain States Medical Group Cardiology

Johnson City, Tennessee, 37601, United States

Location

Knoxville Cardiovascular Research Group, LLC

Knoxville, Tennessee, 37922, United States

Location

Texas Cardiac Arrhythmia

Austin, Texas, 78705, United States

Location

North Texas Heart Center

Dallas, Texas, 75231, United States

Location

Martha Jefferson

Charlottesville, Virginia, 22911, United States

Location

University of Washington Medical Center

Seattle, Washington, 98195, United States

Location

Cardiac Rhythm Specialists, S.C.

Milwaukee, Wisconsin, 53202, United States

Location

Cheyenne Cardiology Associates

Cheyenne, Wyoming, 82001, United States

Location

Fundacion Favaloro para la Docencia e Inv. med.

Buenos Aires, Riodepl, Argentina

Location

Instituto Cardiovascular Buenos Aires (ICBA)

Buenos Aires, Riodepl, Argentina

Location

Biocor Instituto

Nova Lima, Minas Gerais, Brazil

Location

Hospital Beneficiencia Portuguesa de Sao Paulo

São Paulo, Sao Pau, Brazil

Location

Instituto do Coracao (InCor) - HCFMUSP

São Paulo, Brazil

Location

Anhui Provincial Hospital

Hefei, Anhui, China

Location

Guizhou Provincial People's Hospital

Guiyang, Guizhou, China

Location

The First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Location

The 2nd Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, China

Location

APEX Foundation

Medellín, Antioq, Colombia

Location

Care Institute of Medical Sciences

Ahmedabad, Gujarat, India

Location

Holy Family Hospital and Medical Research Center

Mumbai, Mhrshtr, India

Location

Ruby Hall Clinic

Pune, Mhrshtr, India

Location

Delhi Heart and Lung Institute

New Delhi, National Capital Territory of Delhi, India

Location

Escorts Heart Institute and Research Centre

New Delhi, National Capital Territory of Delhi, India

Location

Fortis Flt. Lt. Rajan Dhall Hospital

New Delhi, National Capital Territory of Delhi, India

Location

Medanta - The Medicity Hospital

Gūrgaon, NCT DLH, India

Location

Fortis Escorts Hospital

Amritsar, Punjab, India

Location

Fortis Hospital

Mohali, Punjab, India

Location

The Madras Medical Mission

Chennai, Tmlnadu, India

Location

Fujita Health University School of medicine

Toyoake, Aichi-ken, Japan

Location

Hirosaki University Hospital

Hirosaki-shi, Aomori, Japan

Location

Kokura Memorial Hospital

Kitakyushu, Fukuoka, Japan

Location

Chiba University

Chiba, Japan

Location

Heart Rhythm Management

San Juan, Puerto Rico

Location

Eulji university Hospital Daejeon

Daejeon, Hoseo, South Korea

Location

Samsung Medical Center

Seoul, Sudogwn, South Korea

Location

Yonsei University Health System

Seoul, Sudogwn, South Korea

Location

Related Publications (2)

  • Varma N, Wang JA, Jaswal A, Sethi KK, Kondo Y, Joung B, Yoo D, Auricchio A, Singh JP, Lee K, Gold MR. CRT Efficacy in "Mid-Range" QRS Duration Among Asians Contrasted to Non-Asians, and Influence of Height. JACC Clin Electrophysiol. 2022 Feb;8(2):211-221. doi: 10.1016/j.jacep.2021.09.012. Epub 2021 Nov 24.

  • Varma N, Boehmer J, Bhargava K, Yoo D, Leonelli F, Costanzo M, Saxena A, Sun L, Gold MR, Singh J, Gill J, Auricchio A. Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy. J Am Coll Cardiol. 2019 Nov 26;74(21):2588-2603. doi: 10.1016/j.jacc.2019.09.043.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Clay Cohorn, Clinical Program Director
Organization
Abbott

Study Officials

  • Niraj Varma, MD

    The Cleveland Clinic

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2013

First Posted

March 6, 2013

Study Start

January 1, 2013

Primary Completion

November 1, 2016

Study Completion

September 1, 2017

Last Updated

August 12, 2019

Results First Posted

August 12, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations